National Philanthropic Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

National Philanthropic Trust’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-219,296	Closed	-$4.73M	–	369
2025 Q4	$4.73M	Hold	219,296	–	–	0.05%	103
2025 Q3	$3.35M	Hold	219,296	–	–	0.04%	119
2025 Q2	$1.94M	Hold	219,296	–	–	0.03%	138
2025 Q1	$1.72M	Hold	219,296	–	–	0.03%	131
2024 Q4	$2.3M	Hold	219,296	–	–	0.03%	120
2024 Q3	$2.88M	Hold	219,296	–	–	0.05%	103
2024 Q2	$3.08M	Buy	+219,296	New	+$3.57M	0.06%	95
2024 Q1	–	Sell	-219,296	Closed	-$3.27M	–	274
2023 Q4	$3.1M	Buy	+219,296	New	+$2.58M	0.08%	96

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

National Philanthropic Trust's AVDL Position: Q1 2026 in Review

National Philanthropic Trust sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 219,296 shares — an estimated $4.73M sold.

National Philanthropic Trust first reported a position in AVDL in Q4 2023 and held it in 8 quarters. The position peaked at $4.73M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

National Philanthropic Trust reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
National Philanthropic Trust sold 219,296 Avadel Pharmaceuticals shares in Q1 2026, an estimated $4.73M.
National Philanthropic Trust first reported a position in Avadel Pharmaceuticals in Q4 2023 and held it in 8 quarters.
National Philanthropic Trust's Avadel Pharmaceuticals position peaked at $4.73M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on National Philanthropic Trust's 13F filing for Q1 2026, filed 15 May 2026.